Comparison of clinical instruments for psychosis in Parkinson’s disease
DOI:
https://doi.org/10.31157/an.v19i2.37Keywords:
psychosis, clinical instruments, Parkinson’s disease, Mexican patients.Abstract
Psychosis in patients with Parkinson’s disease is common and to date no adequate clinical instruments for evaluation. Objective: to determine the clinical usefulness of two instruments in the assessment of psychosis in Mexican patients with Parkinson’s disease. Methods: we included patients with Parkinson disease and psychosis. Instruments were applied clìncos TUHARS and UM-PDHQ, and were compared with the scale of positive and negative symptoms. Results: both instruments showed low internal consistency although the correlation between total scores of the two instruments was acceptable but not when compared with the PANSS. Conclusions: using the UM-PDHQ TUHARS in conjunction with the diagnostic criteria of NINDS-NIH may be useful as it develops and publishes a scale with adequate clinimetric properties.Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
